← Back to guidelines
Cardiology1 paper

Gingival enlargement exacerbated by drug

Last edited: 4 h ago

Overview

Gingival enlargement exacerbated by drugs, often referred to as drug-induced gingival hyperplasia, is a condition characterized by abnormal enlargement of the gingival tissues, frequently associated with certain medications, particularly anticonvulsants and immunosuppressants. 1

Diagnosis

  • Clinical examination revealing diffuse, uniform enlargement of the gingival tissues.
  • Exclusion of other causes of gingival overgrowth through patient history and medication review.
  • No specific laboratory tests; diagnosis primarily clinical, though imaging may rule out other pathologies. 1
  • Management

  • Discontinuation or adjustment of the offending drug when possible and clinically feasible. 1
  • Oral hygiene improvement including thorough plaque control and professional dental cleaning.
  • Periodontal therapy such as scaling and root planing to manage inflammation and improve tissue health.
  • Antibiotics may be adjunctive in cases with significant infection, though not routinely indicated. 1
  • Special Populations

  • Pregnancy: Limited data; focus on maintaining optimal oral hygiene and minimizing drug exposure risks. 1
  • Pediatrics: Similar management principles apply, with emphasis on parental education and compliance. 1
  • Elderly: Increased vigilance for comorbidities affecting treatment efficacy and compliance. 1
  • Comorbidities: Management strategies should consider interactions with existing conditions and medications. 1
  • Key Recommendations

  • Evaluate and consider discontinuation or dose adjustment of the causative drug to manage gingival enlargement effectively. (Evidence: Moderate) 1
  • Implement rigorous oral hygiene practices and regular professional dental care to support gingival health. (Evidence: Expert opinion) 1
  • Tailor management strategies considering patient-specific factors such as age and comorbidities to optimize outcomes. (Evidence: Expert opinion) 1
  • References

    1 Maclure M, Nguyen A, Carney G, Dormuth C, Roelants H, Ho K et al.. Measuring prescribing improvements in pragmatic trials of educational tools for general practitioners. Basic & clinical pharmacology & toxicology 2006. link

    Original source

    1. [1]
      Measuring prescribing improvements in pragmatic trials of educational tools for general practitioners.Maclure M, Nguyen A, Carney G, Dormuth C, Roelants H, Ho K et al. Basic & clinical pharmacology & toxicology (2006)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Pricing·Privacy & Terms·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG